Literature DB >> 21140149

Efficacy of a broad host range lytic bacteriophage against E. coli adhered to urothelium.

Sanna Sillankorva1, Dulce Oliveira, Alexandra Moura, Mariana Henriques, Alberta Faustino, Ana Nicolau, Joana Azeredo.   

Abstract

Persistent urinary tract infections (UTI) are often caused by E. coli adhered to urothelium. This type of cells is generally recognized as very tolerant to antibiotics which renders difficult the treatment of chronic UTI. This study investigates the use of lytic bacteriophages as alternative antimicrobial agents, particularly the interaction of phages with E. coli adhered to urothelium and specifically determines their efficiency against this type of cells. The bacterial adhesion to urothelium was performed varying the bacterial cell concentrations and the period and conditions (static, shaken) of adhesion. Three collection bacteriophages (T1, T4, and phiX174 like phages) were tested against clinical E. coli isolates and only one was selected for further infection experiments. Based on the lytic spectrum against clinical isolates and its ability to infect the highest number of antibiotic resistant strains, the T1-like bacteriophage was selected. This bacteriophage caused nearly a 45% reduction of the bacterial population after 2 h of treatment. This study provides evidence that bacteriophages are effective in controlling suspended and adhered cells and therefore can be a viable alternative to antibiotics to control urothelium- adhered bacteria.

Entities:  

Mesh:

Year:  2010        PMID: 21140149     DOI: 10.1007/s00284-010-9834-8

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  18 in total

1.  Culture-independent identification of pathogenic bacteria and polymicrobial infections in the genitourinary tract of renal transplant recipients.

Authors:  Eugen Domann; George Hong; Can Imirzalioglu; Simon Turschner; Johannes Kühle; Corinna Watzel; Torsten Hain; Hamid Hossain; Trinad Chakraborty
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

Authors:  Nuno Cerca; Silvia Martins; Filipe Cerca; Kimberly K Jefferson; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  J Antimicrob Chemother       Date:  2005-06-24       Impact factor: 5.790

Review 3.  Common themes in microbial pathogenicity revisited.

Authors:  B B Finlay; S Falkow
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Robin G Lorenz; Scott J Hultgren
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 5.  Detection of urinary tract infections by rapid methods.

Authors:  M Pezzlo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

6.  Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009.

Authors:  A Lepape; D L Monnet
Journal:  Euro Surveill       Date:  2009-11-12

7.  The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance.

Authors:  A R Costa; M Henriques; R Oliveira; J Azeredo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 3.267

8.  Bacteriophage therapy to reduce salmonella colonization of broiler chickens.

Authors:  R J Atterbury; M A P Van Bergen; F Ortiz; M A Lovell; J A Harris; A De Boer; J A Wagenaar; V M Allen; P A Barrow
Journal:  Appl Environ Microbiol       Date:  2007-05-25       Impact factor: 4.792

9.  T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.

Authors:  H Nishikawa; M Yasuda; J Uchiyama; M Rashel; Y Maeda; I Takemura; S Sugihara; T Ujihara; Y Shimizu; T Shuin; S Matsuzaki
Journal:  Arch Virol       Date:  2008-01-08       Impact factor: 2.574

10.  Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens.

Authors:  C Loc Carrillo; R J Atterbury; A el-Shibiny; P L Connerton; E Dillon; A Scott; I F Connerton
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

View more
  12 in total

1.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Tradeoffs in bacteriophage life histories.

Authors:  Eric C Keen
Journal:  Bacteriophage       Date:  2014-02-27

Review 3.  Managing urinary tract infections through phage therapy: a novel approach.

Authors:  Shikha Malik; Parveen Kaur Sidhu; J S Rana; Kiran Nehra
Journal:  Folia Microbiol (Praha)       Date:  2019-09-07       Impact factor: 2.099

4.  Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities.

Authors:  Shukho Kim; Marzia Rahman; Sung Yong Seol; Sang Sun Yoon; Jungmin Kim
Journal:  Appl Environ Microbiol       Date:  2012-06-29       Impact factor: 4.792

5.  Characterization of a Salmonella Enteritidis bacteriophage showing broad lytic activity against Gram-negative enteric bacteria.

Authors:  Shukho Kim; Sung-Hun Kim; Marzia Rahman; Jungmin Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

6.  Bacteriophages with the ability to degrade uropathogenic Escherichia coli biofilms.

Authors:  Andrew Chibeu; Erika J Lingohr; Luke Masson; Amee Manges; Josée Harel; Hans-W Ackermann; Andrew M Kropinski; Patrick Boerlin
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

7.  Non contiguous-finished genome sequence and description of Enterobacter massiliensis sp. nov.

Authors:  Jean-Christophe Lagier; Khalid El Karkouri; Ajay Kumar Mishra; Catherine Robert; Didier Raoult; Pierre-Edouard Fournier
Journal:  Stand Genomic Sci       Date:  2013-02-22

Review 8.  Phage therapy against Enterococcus faecalis in dental root canals.

Authors:  Leron Khalifa; Mor Shlezinger; Shaul Beyth; Yael Houri-Haddad; Shunit Coppenhagen-Glazer; Nurit Beyth; Ronen Hazan
Journal:  J Oral Microbiol       Date:  2016-09-16       Impact factor: 5.474

9.  Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus.

Authors:  Amy E Kirby
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Front Microbiol       Date:  2018-01-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.